ESR1 and breast carcinoma: The specificity of isoflavones against estrogen receptors or their high-binding affinity with these receptors seen on MCF-7 cells can be used to explain their notable and targeted action against breast cancer cells, including MCF-7, which is positive for ER alpha [39].